PerkinElmer in Agreement to Acquire Caliper Life Sciences
PerkinElmer, (Waltham, Massachusetts), has entered into a definitive agreement to acquire Caliper Life Sciences, (Hopkinton, Massachusetts), with the goal of uniting key technologies for imaging, detection, and sample preparation solutions, services, and expertise.
PerkinElmer, (Waltham, Massachusetts), has entered into a definitive agreement to acquire Caliper Life Sciences, (Hopkinton, Massachusetts), with the goal of uniting key technologies for imaging, detection, and sample preparation solutions, services, and expertise.
The acquisition will allow the company to provide help with translational research by combining imaging, informatics, biomarker detection, assays, and services. Additionally, the move will allow access to complementary solutions ranging from basic research to preclinical studies, diagnostics, and environmental engineering.
Other expected benefits of the agreement include more efficient experimental workflows through an expanded sample preparation portfolio across life science, diagnostics, and environmental markets via microfluidics and DNA purification, and resources that include assay development, automation integration, multivendor asset management, custom research and profiling therapeutics screening, and environmental toxicology.
The purchase of Caliper Life Sciences is expected to close in the fourth quarter, subject to customary closing conditions.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
